What our research found
System Laboratories, Inc. operates the System Labs consumer site. The current terms identify System Labs at 564 Market St in San Francisco. The service describes itself as an online telehealth platform for longevity and preventive-care treatments rather than a dispensing pharmacy.
The care flow begins with treatment selection and a detailed health intake. Product pages call the form a two-minute process and say no appointment is needed. The general FAQ says a licensed provider reviews the history and offers a telemedicine consultation. A prescription is not guaranteed, and the clinician may ask for additional information or refer the patient to in-person care.
System Labs says its clinical team includes U.S.-licensed physicians, nurse practitioners, and physician assistants. It states that providers undergo training, background checks, and National Practitioner Data Bank review. Credentials are available by request and within the patient portal, but the public intake does not identify the patient-specific clinician or medical group in advance.
The current FAQ names The Pharmacy Hub at 15600 NW 15th Avenue, Suite C, Miami, Florida. The Florida Department of Health lists The Pharmacy Hub LLC under pharmacy license PH33959 with a clear status and the same address. System Labs' terms still treat the pharmacy as an independent third party and allow the patient to use another pharmacy.
The normalized comparison section is intentionally short. It contains only compounded subcutaneous sermorelin, NAD+, and glutathione because those records match existing AllyRx active-ingredient and route identities. System Labs' oral dissolving sermorelin, NAD+ nasal spray, glutathione nasal spray, MIC+B12 injection, and topical GHK-Cu formula remain editorial-only rather than becoming extra therapies.
Injectable sermorelin has the clearest recurring schedule. The treatment page states $109 for the first month and $219 per month afterward, including free two-day shipping and no cancellation fee. A current official landing page displays $89 for the first month and a different reference amount. The card therefore uses $219 as the recurring standard rate and treats every introductory price as volatile.
The NAD+ injection page labels a 1,000 mg monthly supply and shows $149 as the reference rate with $89 for the first month. The glutathione injection page labels a 2,000 mg monthly supply and shows $149 with $79 for the first month. Other official catalog, home, and landing surfaces show lower reference or first-month values, so neither card enters direct price ranking until checkout confirms the operative amount.
The broader public catalog currently shows oral sermorelin at $159 with a $79 first month, NAD+ nasal spray at a $100 or $119 reference rate depending on the page, glutathione nasal spray at $169 with a $79 first month, MIC+B12 at $89 per month, and topical GHK-Cu at $109 per month. Those values are not blended into the three injection cards.
Official bundle landing pages introduce another layer of uncertainty. Multi-treatment stacks display component prices, a first-month stack amount, and a later recurring total that do not always reconcile arithmetically. Each treatment is separately prescribed and shipped, so stack totals are excluded from single-medication comparison cards.
Some therapies require baseline laboratory testing. If a clinician decides testing is needed, System Labs says it can order or coordinate the work or the patient can use a local laboratory. The public site does not list one required panel, included-lab promise, cash price, insurance billing pathway, or turnaround time.
System Labs is cash pay and says it does not accept insurance. HSA and FSA handling is unclear: the general FAQ does not confirm either method, while the GHK-Cu page says HSA and FSA payments are accepted. Because a cosmetic topical may not qualify and plan rules vary, this review treats reimbursement eligibility as unverified.
Subscriptions refill automatically. Treatment pages say the member may pause or cancel at any time, while the general FAQ directs cancellation requests to support@systemlabs.com and says a self-service billing portal is coming soon. A newer nasal page says cancellation is available in the account dashboard. No universal cutoff before the next charge is published.
The terms provide the most concrete order cutoff: the patient may cancel before the prescription is sent to the partner pharmacy, in which case the charge should not be captured and a temporary authorization hold should be removed. The FAQ is less specific and says services already rendered or prescriptions already ordered are not refundable. The earlier practical deadline is before pharmacy submission.
Prescription and product sales are final after processing and shipment. A damaged, defective, or incorrect medication must be reported to support within seven days of receipt. System Labs may request photographs and may arrange a replacement at its discretion. If a treatment cannot be filled because of supply or regulatory constraints, the terms say the unfilled order is not charged.
System Labs advertises free two-day delivery. Injection pages describe discreet, temperature-controlled packaging and included administration supplies. Two-day language appears to describe transit rather than the complete interval from intake through review, pharmacy processing, and delivery, and the public site does not provide one end-to-end guarantee.
The platform states that it operates in all 50 U.S. states, but treatment access depends on state telehealth rules and pharmacy licensing and must be confirmed during intake. The clinician and pharmacy responsible for a specific order may therefore differ by patient and state.
System Labs advertises potency, sterility, pH, and endotoxin testing. This is a provider-stated quality claim, not evidence that a compounded product is FDA approved. FDA states that compounded drugs do not receive premarket review for safety, effectiveness, or quality and that FDA does not license pharmacies. The current product and footer disclosures correctly state that the peptide therapies are not FDA approved, while a separate page's FDA-regulated or FDA-registered pharmacy wording should not be read as product approval.
Support is available through provider or care-team messaging and support@systemlabs.com. The contact page tells patients with a medical emergency to call 911. No current general phone support line, service hours, administrative response time, or guaranteed clinician response interval was verified.
The Katalys System Labs application is pending under offer 1575. Internal records show a $100 default payout, treatment-dependent rates up to $200, and a discovery EPC of $9.67. No issued tracking URL or verified affiliate-compatible promotion is available, so the unpublished CTA uses the canonical site and displays no offer. Commercial economics did not affect the score.
- Three normalized cards use active ingredients and the subcutaneous route rather than every marketed product name.
- The Pharmacy Hub is named publicly and its Florida pharmacy license matches the published Miami address.
- Official product, home, catalog, and landing pages display conflicting standard and introductory prices.
- Cancellation is safest before the prescription is sent to the pharmacy; shipped prescription products are final sale.